BiotechTube
Home/axelyf/Arnar Sigurðsson, PhD
AS

Arnar Sigurðsson, PhD

Principal Scientist

axelyf

Therapeutic Areas

OncologyAutoimmune Diseases

axelyf Pipeline

DrugIndicationPhase
AX-004Solid Tumors (in vivo CAR-T)Pre-clinical
AX-003Autoimmune HepatitisPre-clinical

Leadership Team at axelyf

ÖA
Örn Almarsson, PhD
CEO, Co-founder
JL
John Lucas, JD, PhD
Chief Counsel, Co-founder
YX
Yan Xia, PhD
Head of Nanotechnology Formulations
DO
Daniel Omar Frímannsson, PhD
Head of Nucleic Acid Technologies and Biology
View full axelyf profile